12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Gainers

• Redhill Biopharma (NASDAQ:RDHL) shares moved upwards by 38.0% to $1.49 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.5 million.
• Rigel Pharmaceuticals (NASDAQ:RIGL) shares moved upwards by 23.32% to $35.0. The market value of their outstanding shares is at $509.0 million. The company's, Q3 earnings came out yesterday.
• NeuroPace (NASDAQ:NPCE) shares rose 22.55% to $11.52. The company's market cap stands at $310.9 million. As per the press release, Q3 earnings came out yesterday.
• MetaVia (NASDAQ:MTVA) stock rose 12.96% to $1.22. The company's market cap stands at $26.1 million.
• CareDx (NASDAQ:CDNA) stock increased by 11.63% to $16.21. The market value of their outstanding shares is at $772.8 million. The company's, Q3 earnings came out yesterday.
• Veracyte (NASDAQ:VCYT) shares moved upwards by 10.74% to $40.0. The market value of their outstanding shares is at $2.8 billion. As per the news, the Q3 earnings report came out yesterday.

Losers

• Biohaven (NYSE:BHVN) shares declined by 43.1% to $7.94 during Wednesday's pre-market session. The company's market cap stands at $1.4 billion.
• Soleno Therapeutics (NASDAQ:SLNO) shares decreased by 23.65% to $48.75. The market value of their outstanding shares is at $3.3 billion. As per the news, the Q3 earnings report came out yesterday.
• Clover Health Investments (NASDAQ:CLOV) shares fell 19.89% to $2.82. The company's market cap stands at $1.8 billion. As per the news, the Q3 earnings report came out yesterday.
• Akari Therapeutics (NASDAQ:AKTX) shares decreased by 15.01% to $0.7. The market value of their outstanding shares is at $26.7 million.
• Werewolf Therapeutics (NASDAQ:HOWL) shares fell 14.88% to $1.03. The market value of their outstanding shares is at $55.3 million. The company's, Q3 earnings came out yesterday.
• Ultragenyx Pharmaceutical (NASDAQ:RARE) shares decreased by 14.36% to $27.8. The market value of their outstanding shares is at $3.1 billion. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.